A Randomized Controlled Trial to Compare the Clinical Outcomes With Six Months of Therapy With Oral Itraconazole Versus Oral Voriconazole for Management of Treatment naïve Subjects With Chronic Pulmonary Aspergillosis
Conditions
- Chronic Pulmonary Aspergillosis
Interventions
- DRUG: Itraconazole 200 mg
- DRUG: Voriconazole 200mg
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh